Anaemia in patients with myelomatosis.
Twenty-four untreated patients with myelomatosis were studied in order to characterize their anaemia, using standard haematological and ferrokinetic techniques, together with measurements of circulating erythropoietin, erythropoietin sensitivity of marrow cultures and in vitro measurements of haem synthesis. There is a reduction in total erythroid output by the marrow, together with a minor degree of plasma expansion. In patients with normal renal function there is an appropriate increase in erythropoietin in response to anaemia, but in a few cases there may be reduced response of CFU-E to the hormone in vitro. No abnormality of iron status or haem synthesis was found. One case of folate deficiency was discovered.
D000328:Adult; D000368:Aged; D000740:Anemia / Q000150:complications*; D001810:Blood Volume; D001853:Bone Marrow / Q000378:metabolism; D003404:Creatinine / Q000097:blood; D004912:Erythrocytes / Q000378:metabolism; D004921:Erythropoietin / Q000097:blood; D005260:Female; D006418:Heme / Q000096:biosynthesis; D006452:Hemoglobinometry; D006801:Humans; D007136:Immunoglobulins / Q000378:metabolism; D007501:Iron / Q000097:blood; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000150:complications*; D010266:Paraproteins / Q000378:metabolism; D014508:Urea / Q000097:blood
D007136:Immunoglobulins; D010266:Paraproteins; D004921:Erythropoietin; D006418:Heme; D014508:Urea; D003404:Creatinine; D007501:Iron